Serum paraoxonase

Details Serum paraoxonase Serum paraoxonase

2006-04-11

2006-04-11

Chan, Christina (Department: 1644)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Using tissue cell culture to make a protein or polypeptide

C435S005000, C435S183000, C435S326000, C530S350000, C530S809000, C530S388260

Reexamination Certificate

active

07026140

ABSTRACT:
Human serum paraoxonase enzyme and DNA (RNA) encoding such serum paraoxonase enzymes are disclosed. Also provided is the procedure for producing such polypeptides by recombinant techniques. Uses of such polypeptides include their use as an antidote for organophosphate poisoning and to prevent neuronal cell death.

REFERENCES:
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5260203 (1993-11-01), Ladner et al.
patent: 5629193 (1997-05-01), Hudson et al.
patent: 5792639 (1998-08-01), Hudson et al.
patent: 6140093 (2000-10-01), Hudson et al.
patent: 6180370 (2001-01-01), Queen et al.
patent: WO-96/01322 (1996-01-01), None
Hassett et al, Biochemistry 30: 10141-10149, 1991.
Campbell et al in Monoclonal Antibody Technology, 1984, Elsevier Science Publisher, New York, NY, p. 1-32.
Harlow et al, in Antibodies a Laboratory Manual, 1988, Cold Spring harbor laboratory publication, Cold Spring Harbor, NY, pp. 92-94, pp. 139-153.
Orfanoudakis et al, Mol Immunol 30(16): 1519-1528, Nov. 1993.
Adkins et al., “Molecular Basis for the Polymorphic Forms of Human Serum Paraoxonase/Arylesterase: Glutamine or Arginine at Position 191, for the Respective A or B Allozymes”,Am. J. Hum. Genet. 52:598-608 (1993).
Furlong et al., “Human and Rabbit Paraoxonases: Purification, Cloning, Sequencing, Mapping and Role of Polymorphism in Organophosphorus Detoxification”,Chem. Biol. Interactions87:35-48 (1993).
La Du et al., “Studies on Human Serum Paraoxonase Arylesterase”,Chem. Biol. Interactions87:25-34 (1987).
Hassett et al., “Characterization of cDNA Clones Encoding Rabbit and Human Serum Paraoxonase: The Mature Protein Retains Its Signal Sequence”,Biochemistry30(42):10141-10149 (1992).
Adkins et al., “Recombinant Human Paraoxonase Has Both Organophosphatase and Arylesterase Activities”,FASEB Journal7(4):A803 (1993).
Shaw et al., “Nucleotide Sequence of a Novel Arylesterase Gene FromVibrio mimicusand Characterization of the Enzyme Expressed inEscherichia coli”, Biochem. Journal298(3):675-680 (1994).
Smolen et al., “Characteristics of the Genetically Determined Allozymic Forms of Human Serum Paraoxonase Arylesterase”,Drug Metabolism and Disposition19:107-112 (1991).
Humbert et al., “The molecular basis of the human serum paraoxonase activity polymorphism”,Nature Genetics3:73-76 (1993).
Kawai et al., “ELISA using monoclonal antibody to human serum arylesterase”,Clinica Chimica Acta202:219-226 (1993).
Harlow et al. (in Antibodies a Laboratory Manual, 1988, Cold Spring Harbor Laboratory publication, Cold Spring Harbor, NY, pp. 92-94, pp. 116-117, pp. 591-599).
Tanaka-Kawai et al., “Molecular weight and substrate characteristics of human serum arylesterase following purification by immuno-affinity chromatography”,Clinica Chimica Acta215(2):127-138 (1993).
Blatter et al., “Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45,”Eur. J. Biochem. 211:871-879 (1993).
Primo-Parmo et al., “The Human Serum Paraoxonase/Arylesterase Gene (PON1) Is One Member of a Multigene Family,”Genomics33:498-507 (1996).

Affiliated with

Also associated with

Rating

Serum paraoxonase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Serum paraoxonase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serum paraoxonase will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3623133